Navigation Links
The Quigley Corporation Issues Open Letter to Stockholders; Urges Stockholders to Reject Dissident Ted Karkus' Solicitation Efforts
Date:5/7/2009

you should have received The Quigley Corporation proxy statement for our 2009 Annual Meeting, along with a WHITE proxy card. We urge all stockholders to protect your investment and vote the WHITE card immediately. Disregard any proxy materials you may receive from dissident stockholder Ted Karkus, who is seeking to replace your Company's entire incumbent Board of Directors.

MANAGEMENT'S STRATEGIC PLAN HAS BEEN CAREFULLY DEVELOPED AND

EXECUTED - AND IT'S WORKING!

The Quigley Corporation, under the guidance of the incumbent Board and management, has a carefully developed long term strategic plan to increase stockholder value by investing a share of the profits from its successful, market leading OTC homeopathic cold remedy to self-fund research and development of naturally-derived medicinal compounds for which there is enormous market potential.

On April 30, 2009 the Company issued a major announcement regarding noteworthy results from Phase II testing of its QR-333 compound to treat Diabetic Peripheral Neuropathy:

POSITIVE FINDING FOR QR-333 COMPOUND TO TREAT DIABETIC PERIPHERAL

NEUROPATHY EXPANDS POTENTIAL

Diabetic Peripheral Neuropathy is a common complication of diabetes associated with nerve damage in the feet and hands. According to the American Diabetes Association, over 20 million people in the U.S. have diabetes, which grew 13.5% from 2005 to 2007. According to Datamonitor, the market for drugs to treat this problem is $2.8 billion today and is expected to grow to $6.0 billion by 2017. The clinical study of the QR-333 compound showed a sizeable increase in nerve conduction speed and strength of sensory nerve signals, suggesting that the compound may have the potential to both reverse and stop nerve damage. Your management team is on track to explore multiple next step options for the compound, which i
'/>"/>

SOURCE The Quigley Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. The Quigley Corporation Reports First Quarter 2009 Results
2. Unexpected Positive Finding Expands Potential for Quigley QR333 Drug for Diabetic Neuropathy; Findings Suggest Possible Disease Modification
3. The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future
4. Quigley Announces Completion of Phase IIb Clinical Study of QR-333 For Diabetic Peripheral Neuropathy on November 25, 2008; Collection and Evaluation of Study Data to Begin Immediately Thereafter
5. The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
6. The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director
7. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
8. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
9. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
10. Service Corporation International Announces First Quarter 2009 Financial Results
11. Providence Service Corporation Announces Record Revenues and Earnings in the First Quarter of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 For over 20 years, ... Oceanside and Vista area has treated just about every ... personal injury circumstances. And for those same twenty-plus years, the ... of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a ... insurance policy . , Some types of vehicles cannot be ... newly released blog post to see if their vehicle qualifies for ... are some of the cars that cannot be covered by a ...
(Date:12/26/2014)... Dallas, TX (PRWEB) December 26, 2014 The ... covered in this report. In 2013, GlobalData’s forecast estimates that ... the largest CRC market due to the high incidence of ... compared with the 5EU, Japan, and China. Increased sales of ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... have slowed to less than half the growth rate from ... in the health care system continue to fuel underlying health ... , , Prepared by PricewaterhouseCoopers ... Factors Fueling Rising Healthcare Costs 2008" examines the causes of ...
... The Michigan Quality Council,(MQC) announces that the Detroit Athletic ... The Michigan Quality Leadership Award is ... It is awarded after a,rigorous review by a team of ... report for final evaluation to an independent panel of,judges. , ...
... definitively that blood stem cells are made during mid-gestational embryonic ... of blood vessels. , While the anatomic location in ... documented, the cell type from which they spring was less ... issue of the journal Cell Stem Cell , puts ...
... Dec. 3 BeaconEquity.com announces the availability of Trade Alerts on stocks making ... all of the daily trading notes for free by visiting: http://www.BeaconEquity.com/m ... Inc. (NYSE: SPC ), Williams-Sonoma Inc. (NYSE: WSM ), ... WXS ), Morgans Hotel Group Co. (Nasdaq: MHGC ) and ...
... U.S. Environmental Protection Agency,s process of generating risk assessments ... harmful chemicals found in the environment in order to ... challenges, and as a decision-making tool it is often ... the information needs of officials, says a new report ...
... CEO of Americans United for Life released the following statement ... make funding embryo destructive stem cell research a priority. , ... of the economy, to squander taxpayer resources on research that ... that in fact runs counter to the latest stem cell ...
Cached Medicine News:Health News:New Report Shows Slower Premium Growth, But Increasing Pressure to Address Waste in Health Care System 2Health News:New Report Shows Slower Premium Growth, But Increasing Pressure to Address Waste in Health Care System 3Health News:MICHIGAN QUALITY COUNCIL (MQC) NAMES The Detroit Athletic Club 2008 STATE QUALITY AWARD RECIPIENT 2Health News:UCLA scientists prove endothelial cells give rise to blood stem cells 2Health News:UCLA scientists prove endothelial cells give rise to blood stem cells 3Health News:Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: SPC, WSM, MRX, WXS, MHGC, DSPG 2Health News:EPA's risk assessment process bogged down by unprecedented challenges; 2Health News:EPA's risk assessment process bogged down by unprecedented challenges; 3Health News:EPA's risk assessment process bogged down by unprecedented challenges; 4
(Date:1/23/2015)... MYERS, Fla. , Jan. 23, 2015  Today the ... of Novartis, Bexsero® for the prevention of serogroup ... 25. Bexsero and Pfizer,s vaccine Trumenba®, which received FDA ... helping prevent this devastating disease. "I ...
(Date:1/23/2015)... Partnership to Fight Chronic Disease (PFCD) released a public opinion poll ... new study analyzing the impact of increased cost sharing on patient ... to educate policy makers and the public on the costs of ... how the Iowa healthcare exchange could be ...
(Date:1/23/2015)... , Jan. 23, 2015 More than a third ... quarter of those with private insurance, filled a prescription for ... a report in this week,s Morbidity and Mortality Weekly Report ... care providers to treat moderate to severe pain.  They are ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... Data from experimental work on the use,of ... this week at the,International Society for Heart and ... donors after cardiac death,(DCD), also known as non-heart-beating ... shortage of suitable donor organs for lung, and,possibly ...
... Institute,s NABTT ... Consortium -, ... expansion of the clinical program for the company,s lead,product candidate, BSI-201, ... first poly ADP-ribose polymerase,(PARP) inhibitor in BiPar,s DNA repair portfolio, crosses ...
Cached Medicine Technology:Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation 2Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation 3BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer 2
... your practice with the advantages of the IPL ... of leg veins and other deeper vascular lesions. ... As a stand alone device or as an ... DL treats a range of conditions including: ...
Disposable. Sterile Suction Tubing....
... say the most efficient,aspiration is ... movement of the,cannula tip. Rigorous ... ARC-H II Reciprocating Cannula,assures that ... is,restricted to a longitudinal axis ...
Inquire...
Medicine Products: